AtriCure, Inc. vs Johnson & Johnson — Stock Comparison

ATRC
AtriCure, Inc.
$29.02
▲ 3.24%
vs
JNJ
Johnson & Johnson
$227.19
▼ 1.16%
Q·Score Winner
Johnson & Johnson
JNJ7.1/10vs 6.7/10

Q·Score Breakdown

6.7
Neutral
Overall
7.1
Bullish
3.7
Quality
9.3
9.7
Health
6.5
7.5
Growth
5.1
6.3
Valuation
7.3
7.4
Sentiment
6.5
ATRC

Clean balance sheet with low leverage (0.2× debt-to-equity).

currently unprofitable (-2% margin).

JNJ

High-quality business with 26% return on equity and 22% profit margins.

earnings contracting 53% year-over-year.

Analyst Consensus

BUY
Target $46.75 (+61.1%)
8 analysts
BUY
Target $252.42 (+11.1%)
24 analysts

Fundamentals

ATRC
JNJ
Trailing P/E
26.3×
78.5×
Forward P/E
17.9×
-2.1%
Profit Margin
21.8%
75.0%
Gross Margin
68.0%
-2.4%
ROE
26.4%
13.1%
Revenue Growth
9.9%
Earnings Growth
-52.9%
1.43
Beta
0.33
Price / Book
$1.5B
Market Cap
$546.9B
$27 – $43
52-Week Range
$146 – $252

Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →